We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter to North Carolina Outsourcing Facility
FDA Issues Warning Letter to North Carolina Outsourcing Facility
Exela Pharma Sciences drew a warning letter from the FDA for inadequate procedures for reporting adverse events and other lapses observed during an agency inspection of its drug outsourcing facility in Lenoir, North Carolina.